Table 1 Electrocardiographic parameters after six weeks of VLDLs injection.

From: Very-Low-Density Lipoprotein of Metabolic Syndrome Modulates Gap Junctions and Slows Cardiac Conduction

 

Control (n = 10)

nVLDL (n = 10)

msVLDL (n = 10)

p value

BW (g)

27.3 ± 1.4

29.1 ± 1.9

27.3 ± 2.3

0.0678*

HR (bpm)

355.5 ± 98.2

406.4 ± 60.3

345.5 ± 112.6

0.3068

P width (msec)

19.4 ± 6.4

19.3 ± 5.6

27.8 ± 12.3

0.0414¶#

P amplitude (mV)

0.053 ± 0.024

0.051 ± 0.027

0.082 ± 0.016

0.0068¶#

PR (msec)

47.4 ± 12.2

54.3 ± 10.6

71.4 ± 16.8

0.0140¶#

QRS (msec)

23.6 ± 8.1

23.7 ± 6.7

40.7 ± 16.9

0.0028¶#

QT (msec)

58.0 ± 27.3

55.7 ± 22.2

110.0 ± 41.7

0.0008¶#

QTc (msec)

46.3 ± 18.2

46.4 ± 17.1

71.5 ± 14.7

0.0025¶#

  1. BW, body weight; HR, heart rate; P, P wave; PR, PR intervals; QRS, QRS durations; QT, QT intervals; QTc, corrected QT intervals. Data are mean ± SD. *Comparison significant for nVLDL versus Control. Comparison significant for msVLDL versus Control. #Comparison significant for msVLDL versus nVLDL.
Back to article page